Unfavorable Outcomes Due To C. Diff Most Common Among Patients Infected With NAP1/BI/R027 Strain, Study Finds

Infectious Disease Advisor (4/12, Barowski) reported, “In regard to specific strains of Clostridioides difficile, NAP1/BI/R027 is the most frequently detected among patients with unfavorable clinical outcomes, according to study results published in Open Forum Infectious Diseases.” In the study, “pooled rates of 30-day attributable mortality were highest in patients infected with NAP1/R027 (10.2%; 95% CI, 6.5-15.5), followed by those infected with R078, R001, and R014 (5.3%, 3.8%, and 1.7%, respectively).”